Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation-Reference-Cited by-同舟云学术

Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

Published:2022-06 Issue:6 Volume:22 Page:1671-1682
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Rodríguez-Perálvarez Manuel^ORCID,Colmenero Jordi^ORCID,González Antonio^ORCID,Gastaca Mikel^ORCID,Curell Anna^ORCID,Caballero-Marcos Aránzazu^ORCID,Sánchez-Martínez Ana^ORCID,Di Maira Tommaso^ORCID,Herrero José Ignacio^ORCID,Almohalla Carolina^ORCID,Lorente Sara^ORCID,Cuadrado-Lavín Antonio^ORCID,Pascual Sonia^ORCID,López-Garrido María Ángeles^ORCID,González-Grande Rocío^ORCID,Gómez-Orellana Antonio^ORCID,Alejandre Rafael^ORCID,Zamora-Olaya Javier^ORCID,Bernal-Bellido Carmen^ORCID

Funder

Consejería de Salud y Familias, Junta de Andalucía

Universidad de Córdoba

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.17021

Reference36 articles.

1. 2018 annual report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation;Adam;Transpl Int.,2018

2. Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study;Åberg;Hepatology.,2015